Mosadong Ebola vaccine begins to be vaccinated in Guinea's disaster stricken communities

Source: Biovalley March 27, 2015 Guinea began to vaccinate the Ebola vaccine developed by Merck & Co, a US pharmaceutical giant, and newlink genetics in the Ebola disaster community this week Through this action, officials hope to accelerate the end of the most serious Ebola epidemic in history According to statistics, since the outbreak of Ebola in December 2013, there have been more than 20000 confirmed or suspected cases and more than 10200 deaths Although the Ebola epidemic has slowed throughout West Africa, the number of cases in Guinea has increased again in recent weeks The World Health Organization (who) plans to vaccinate about 10000 people in the next six to eight weeks Health workers will immunize people in high-risk contact with Ebola patients to create an immune reserve around them Guinean officials say a safe and effective vaccine will help us put an end to the Ebola epidemic and start rebuilding our homes through control measures carried out by joint partners The who said that the Ebola vaccine developed by MSD has been vaccinated for some volunteer medical staff The first team of the phase III clinical trial arrived in a village in Western Guinea on March 23 and received a very good response, which is a major disaster area of the Ebola epidemic in the country However, some people are concerned that the vaccination campaign may be violently resisted by some communities Earlier, due to rumors of credulity, Guinean residents had attacked medical staff with stones and machetes There are rumors that doctors and nurses are planning to infect local residents with Ebola virus; there are also rumors that doctors and nurses have carefully planned the Ebola plot to obtain human organs at the Ebola treatment center Jerome Mouton, head of MSF, a charity in Guinea's fight against Ebola, said the vivid depiction of "some people coming with syringes" was the cause of all the rumors In addition, the stimulation of immune response after vaccination may cause fever, which is one of the early symptoms of Ebola infection The WHO (WHO) said people would not be forced to get vaccinated In an interview with Reuters, Alasan senghore, head of the African Red Cross, said overcoming these obstacles is the biggest challenge to ending the Ebola epidemic, which in reality will last until the end of the year In February, two more clinical trials of the vaccine were launched in Libya, at a time when there were also conspiracy statements about doctors and nurses using the Ebola virus to infect local people in some remote areas of the country Mosadon and newlink reached a cooperation in December last year The experimental vaccine vsv-zebov jointly developed by the two sides adopted a defective vesicular stomatitis virus that can infect domestic animals, replacing one gene of the virus with that of Ebola virus